同时出现性十二指肠炎和性结肠炎,对戈利马布和乌斯特基马布表现出独特的反应
Sho Masaki1, Hajime Honjo1, Masayuki Kurimoto1
1Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.
Clinical journal of gastroenterology
|July 18, 2024
概括
这项研究详细介绍了一例性结肠炎 (UC) 与性十二指肠炎 (UD) 的病例,该病例显示了对生物制剂的独特反应. 乌斯特基努马布 (UST) 有效治疗了这两种疾病,突出了TNF-α和IL-12/23p40作为潜在的致病性细胞因子.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 上部胃肠道 (UGI) 炎症发生在性结肠炎 (UC) 患者中.
- 在UC相关的UGI病变中,致病性细胞因子 (cytokine) 概况和生物反应尚不清楚.
研究的目的:
- 在同时发生UC和性十二指肠炎 (UD) 的情况下,研究细胞因子概况和生物治疗反应.
主要方法:
- 关于并发UC和UD的案例报告.
- 使用普得尼索隆 (PSL),戈利穆马布 (GLM) 和乌斯特基努马布 (UST) 的治疗.
- 在十二指肠和直肠粘膜中对TNF-α表达的免疫光分析.
主要成果:
- 在UC和UD两种情况下,PSL未能诱导缓解.
- 对于UD和UC,GLM和UST分别是有效的;UST在两种情况下都实现了缓解.
- 治疗后的TNF-α水平与UD活性相关,但与UC活性无关.
- 在GLM/UST的十二指肠减少TNF-α;在GLM/PSL的结肠减少TNF-α,没有缓解.
结论:
- 同时的UC和UD可以对生物药物表现出不同的反应.
- 在UD中,TNF-α似乎具有病原性,而IL-12/23p40在这种情况下可能在UC中具有病原性.
- UST在治疗并发性UD和UC时都表现出有效性.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Chronic Bowel Disorders: Introduction
438
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
438
Drugs for Treatment of Ulcerative Colitis in IBD
134
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
134
Inflammatory Bowel Disease II: Crohn's Disease
210
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
210
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
127
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
127
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


